Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS

NCT02200952 · clinicaltrials.gov ↗

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Hyperstimulation Syndrome

Interventions

DRUG: recombinant LH

Sponsor

San Carlo Public Hospital, Potenza, Italy